istock-509483224-pills-2
27 March 2018Americas

Shire welcomes Adderall generic ruling

A US judge handed a win to Shire late last week, finding that a generic version of its attention deficit hyperactivity disorder drug Adderall XR (amphetamine/dextroamphetamine mixed salts) would infringe Shire’s patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia-Pacific
3 April 2018   Japan-based Takeda has revealed that it is considering plans to acquire biopharmaceutical company Shire.

More on this story

Asia-Pacific
3 April 2018   Japan-based Takeda has revealed that it is considering plans to acquire biopharmaceutical company Shire.

More on this story

Asia-Pacific
3 April 2018   Japan-based Takeda has revealed that it is considering plans to acquire biopharmaceutical company Shire.